| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 51 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 324.9K | $168.62M | -76,000 | |
| VP | 40.2K | $20.86M | - | |
| CFO | 18.9K | $9.80M | - | |
| Dir | 17.6K | $9.12M | - | |
| CFO | Edgemond James | 11.7K | $6.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Causey Christopher59 | Director | Sale+OE | 1,000 | $510.00 | $510,000.00 | -19.3% | +11.3% | - | |
| Jan 5, 2026 | Benkowitz Michael47 | President And COO | Sale+OE | 14,625 | $487.38 | $7,127,877.16 | -13.8% | +14.3% | - | |
| Jan 5, 2026 | Benkowitz Michael47 | President And COO | Sale+OE | 7,875 | $487.38 | $3,838,084.96 | -13.8% | +14.3% | - | |
| Jan 5, 2026 | Malcolm Jan | Director | Sell | 50 | $495.01 | $24,750.50 | -11.9% | +14.3% | - | |
| Jan 2, 2026 | Causey Christopher59 | Director | Sale+OE | 1,000 | $500.01 | $500,014.60 | -19.3% | +14.8% | - | |
| Jan 2, 2026 | Mahon Paul A46 | EVP &General Counsel | Sale+OE | 8,300 | $485.43 | $4,029,076.32 | -2.5% | +14.8% | - | |
| Dec 29, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 22,500 | $502.79 | $11,312,709.75 | -100% | +17.0% | - | |
| Dec 24, 2025 | Mahon Paul A46 | EVP &General Counsel | Sale+OE | 11,000 | $513.18 | $5,644,953.77 | -3.5% | +3.3% | - | |
| Dec 23, 2025 | Malcolm Jan | Director | Sell | 50 | $512.12 | $25,606.00 | -10.6% | +2.1% | - | |
| Dec 22, 2025 | Sullivan Louis W62 | Director | Sale+OE | 5,950 | $512.13 | $3,047,200.66 | -55.0% | +1.4% | - |